Analysis of gene expression and copy number variation (CNV) data of pancreatic cancer patients in the TCGA database reported that patients with ALKBH5 CNV have a worse prognosis and that increased expression of ALKBH5 is positively correlated with activation of AKT pathways [55]. This evidence concerns the gene ALKBH5 and familial pancreatic carcinoma.